Sanofi researches, develops, manufactures, and markets various therapeutic solutions. The company operates in three segments: Pharmaceuticals, Vaccines, and Animal Health. The company was founded in 1973 and is based in Paris, France.
SNY Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Sanofi with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Sanofi ranked in the 55th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 17.83%. In terms of the factors that were most noteworthy in this DCF analysis for SNY, they are:
The stock's equity weight, or the proportion of capital from equity relative to debt, is 69. Its equity weight surpasses that of only 19.54% of free cash flow generating stocks in the Healthcare sector.
Sanofi's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 6.21% of tickers in our DCF set.
SNY's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than only 6.21% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Sanofi? See PRAH, UNH, REGN, CMD, and DXCM.
Antibodies are blood protein. Every specific antigen has a specific antibody manufactured by the body. They are generally called immunoglobulin and are usually in the shape of the Y structure. Upgrades in technology, especially in the field of genetic engineering
Coherent Market Insights has recently updated its massive report catalog by adding a fresh study titled "Global Biologics Market – Industry Analysis, Size, Share, Growth, Trends, & Forecast 2020 – 2027". This business intelligence study encapsulates vital details about the
Latest Survey On Human Insulin Market: ‘Market Growth Insight’ has presented an updated research report on ‘The Global Human Insulin market’ which offers insights on key aspects and an overview of the fundamental verticals of the market. The Human Insulin report
The Vaccine statistical surveying report contains market experiences and investigation for Pharmaceutical industry which are sponsored up by SWOT examination. According to the expectations refered to in this report, the market will develop with a particular CAGR esteem in the